safety And NotIngersoll
List of bibliographic references
Number of relevant bibliographic references: 4.Ident. | Authors (with country if any) | Title |
---|---|---|
001557 | Cheryl H. Waters [États-Unis] ; Kapil D. Sethi [États-Unis] ; Robert A. Hauser [États-Unis] ; Eric Molho [États-Unis] ; John M. Bertoni [États-Unis] | Zydis selegiline reduces off time in Parkinson's disease patients with motor fluctuations: A 3‐month, randomized, placebo‐controlled study |
001648 | Matthew B. Stern [États-Unis] ; Kenneth L. Marek [États-Unis] ; Joseph Friedman [États-Unis] ; Robert A. Hauser [États-Unis] ; Peter A. Lewitt [États-Unis] ; Daniel Tarsy [États-Unis] ; C. Warren Olanow [États-Unis] | Double‐blind, randomized, controlled trial of rasagiline as monotherapy in early Parkinson's disease patients |
001898 | Werner Poewe [Autriche] ; G. Deuschl ; A. Gordin [Finlande] ; E. Kultalahti [Finlande] ; M. Leinonen [Finlande] | Efficacy and safety of entacapone in Parkinson's disease patients with suboptimal Levodopa response: a 6‐month randomized placebo‐controlled double‐blind study in Germany and Austria (Celomen study) |
001A00 | V. V. Myllyl ; E. Kultalahti [Finlande] ; H. Haapaniemi [Finlande] ; M. Leinonen [Finlande] | Twelve‐month safety of entacapone in patients with Parkinson’s disease |
This area was generated with Dilib version V0.6.23. |